1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Adrenal Abcg1 Controls Cholesterol Flux and Steroidogenesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cholesterol is the precursor of all steroids, but how cholesterol flux is controlled in steroidogenic tissues is poorly understood. The cholesterol exporter ABCG1 is an essential component of the reverse cholesterol pathway and its global inactivation results in neutral lipid redistribution to tissue macrophages. The function of ABCG1 in steroidogenic tissues, however, has not been explored. To model this, we inactivated Abcg1 in the mouse adrenal cortex, which led to an adrenal-specific increase in transcripts involved in cholesterol uptake and de novo synthesis. Abcg1 inactivation did not affect adrenal cholesterol content, zonation, or serum lipid profile. Instead, we observed a moderate increase in corticosterone production that was not recapitulated by the inactivation of the functionally similar cholesterol exporter Abca1. Altogether, our data imply that Abcg1 controls cholesterol uptake and biosynthesis and regulates glucocorticoid production in the adrenal cortex, introducing the possibility that ABCG1 variants may account for physiological or subclinical variation in stress response.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          The contribution of de novo coding mutations to autism spectrum disorder.

          Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mechanisms and regulation of cholesterol homeostasis

            Cholesterol homeostasis is vital for proper cellular and systemic functions. Disturbed cholesterol balance underlies not only cardiovascular disease but also an increasing number of other diseases such as neurodegenerative diseases and cancers. The cellular cholesterol level reflects the dynamic balance between biosynthesis, uptake, export and esterification - a process in which cholesterol is converted to neutral cholesteryl esters either for storage in lipid droplets or for secretion as constituents of lipoproteins. In this Review, we discuss the latest advances regarding how each of the four parts of cholesterol metabolism is executed and regulated. The key factors governing these pathways and the major mechanisms by which they respond to varying sterol levels are described. Finally, we discuss how these pathways function in a concerted manner to maintain cholesterol homeostasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands

              Congenital heart disease (CHD) is the leading cause of mortality from birth defects. Exome sequencing of a single cohort of 2,871 CHD probands including 2,645 parent-offspring trios implicated rare inherited mutations in 1.8%, including a recessive founder mutation in GDF1 accounting for ~5% of severe CHD in Ashkenazim, recessive genotypes in MYH6 accounting for ~11% of Shone complex, and dominant FLT4 mutations accounting for 2.3% of Tetralogy of Fallot. De novo mutations (DNMs) accounted for 8% of cases, including ~3% of isolated CHD patients and ~28% with both neurodevelopmental and extra-cardiac congenital anomalies. Seven genes surpassed thresholds for genome-wide significance and 12 genes not previously implicated in CHD had > 70% probability of being disease-related; DNMs in ~440 genes are inferred to contribute to CHD. There was striking overlap between genes with damaging DNMs in probands with CHD and autism.
                Bookmark

                Author and article information

                Contributors
                Journal
                Endocrinology
                Endocrinology
                endo
                Endocrinology
                Oxford University Press (US )
                0013-7227
                1945-7170
                March 2024
                01 February 2024
                01 February 2024
                : 165
                : 3
                : bqae014
                Affiliations
                Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Kuopio Pediatric Research Unit (KuPRU), University of Eastern Finland and Kuopio University Hospital , Kuopio 70200, Finland
                Department of Chemistry, Biochemistry and Pharmacy, Medical Faculty, University of Bern , Bern 3010, Switzerland
                Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern , Bern 3010, Switzerland
                Department of Pediatrics, Harvard Medical School, Boston Children's Hospital , Boston, MA 02115, USA
                Harvard Stem Cell Institute , Cambridge, MA 02138, USA
                Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital , Bern 3010, Switzerland
                Department for BioMedical Research, University Hospital Inselspital, University of Bern , Bern 3010, Switzerland
                Author notes
                Correspondence: Emanuele Pignatti, PhD, Pädiatrische Endokrinologie/Diabetologie/Metabolik, Medizinische Universitätskinderklinik Bern, Freiburgstrasse 15/C843, Bern 3010, Switzerland. Email: emanuele.pignatti@ 123456unibe.ch .

                Christa E Flück and Emanuele Pignatti contributed equally.

                Author information
                https://orcid.org/0000-0001-6076-1512
                https://orcid.org/0000-0002-5372-5692
                Article
                bqae014
                10.1210/endocr/bqae014
                10863561
                38301271
                79192a58-b308-4fd4-94cb-603abd06a73a
                © The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 November 2023
                : 29 January 2024
                : 13 February 2024
                Page count
                Pages: 10
                Funding
                Funded by: Novartis Foundation for Medical-Biological Research, DOI 10.13039/501100004784;
                Award ID: 22B088
                Funded by: NCCR RNA&Disease Translational Fellowship Grant;
                Funded by: International Fund Congenital Adrenal Hyperplasia;
                Funded by: University of Bern via the Initiator;
                Funded by: Uniscientia Foundation Zürich/Vaduz;
                Funded by: Sigrid Jusélius Foundation, DOI 10.13039/501100006306;
                Funded by: Foundation for Pediatric Research, DOI 10.13039/501100005744;
                Categories
                Research Article
                AcademicSubjects/MED00250

                Endocrinology & Diabetes
                abcg1,cholesterol,glucocorticoids,steroids,adrenal cortex
                Endocrinology & Diabetes
                abcg1, cholesterol, glucocorticoids, steroids, adrenal cortex

                Comments

                Comment on this article